Our study uncovered a novel mechanism underlying CLL cell upregulation of MMP-9, which prior studies found at higher levels in the plasma of CLL patients compared to healthy individuals [21]. This evidence concerns the gene MMP9 and B-cell chronic lymphocytic leukemia.